Daglige arkiver: 27. januar 2023

Ukens leder

I forrige uke lanserte Helse- og omsorgsminister Ingvild Kjerkol og regjeringen en ny strategi for persontilpasset medisin Strategi for persontilpasset medisin – regjeringen.no. Det er et uttrykt mål at persontilpasset medisin skal være en integrert del av helsetjenesten. Nasjonale registre, «big data» og bruk av kunstig intelligens, samt klinisk forskning trekkes frem som felt som integrerer pasientbehandling, systematisk kunnskapsbygging og forskning. Strategien kan leses som et signal om økt fokus på forskning i klinikk og undervisning – og som støtte for at det gode samarbeidet vi på K2 tilstreber mellom universitet og helseinstitusjoner, er viktig.

Ett av strategiens mål er særlig aktuelt for oss som undervisere på K2. Det handler om at vi må utdanne fagfolk til helsetjenestene som har relevant kompetanse til å ta i bruk og utvikle persontilpasset forebygging, diagnostikk, behandling og oppfølging. Fordi feltet er i rask utvikling og krever bruk av avansert teknologi og metoder, peker strategien på at vi må koordinere utdanningstilbudene i universitets- og høyskolesektoren, samtidig som livslang læring blir viktig. De helsefaglige grunn- og videreutdanningene beskrives som sentrale for å ivareta kompetansebehovene innenfor persontilpasset medisin. Det forventes at disse kompetansebehovene vil endres for flere faggrupper, og vi må regne med tilpasninger gjennom RETHOS. Eksempler som nevnes er behov for utvikling av undervisningen i f.eks. molekylær patologi og mikrobiologi og bruk av avanserte digitale beslutningsverktøy og analyser baser på kunstig intelligens.

Minner om at fristen nærmer seg for å nominere kandidater til fakultetets priser for forskning og undervisning. Vi fra K2 kan fremme en kandidat i hver kategori, så ikke nøl med å sende inn forslag (med utfyllende begrunnelse) innen mandag 6. februarMer detaljert informasjon finnes her.

Mette Vesterhus
Utdanningsleder K2

Global Health Challenges and Solutions

MatchPoints Conference, 11–13 May 2023
Aarhus University, Denmark

The Covid-19 pandemic has shown how quickly a disease can spread across the globe with devastating consequences for people’s health and the world’s economies. And it’s unlikely to be a one-off. Whilst some infectious diseases are being eradicated, new and unknown diseases are emerging – and many diseases that can be treated in countries with advanced healthcare systems are spreading in parts of the world less able to handle them.

https://matchpoints.au.dk/

EMBO Young Investigator Programme

The EMBO Young Investigator Programme supports life scientists who have been group leaders for less than four years at the time of application in setting up their laboratories. Young Investigators receive financial support for networking for four years and benefit from training opportunities, support for their lab members and mentoring. They become part of an international network of more than 600 current and former EMBO Young Investigators, Installation Grantees and Global Investigators.

https://www.embo.org/funding/fellowships-grants-and-career-support/young-investigator-programme/

UIB Opp 2.15 Preparing for your next Horizon Europe proposal

This course will provide a practical guide on how to build on past and current projects funded by the EU, navigate the vast Horizon Europe framework program, and build core concept of research proposals.

The European framework program Horizon Europe supports is the EU’s main funding programme for research and innovation. Running from 2021 to 2027 with a budget of 95.5 billion euros, it is the most extensive research funding programme globally. It supports a wide range of research and innovation activities, including primary and applied research, innovation projects, and networking activities, and provides funding and opportunities for researchers in all fields and at all career stages.

28.02.2023 – 09.00–11.30
FIA sine lokaler, Jekteviksbakken 31, 2. etg.
Hiwa Målen

Påmeldingsfrist: 21.02.2023 – 12.00

Påmeldingsskjema UiB Opp 2.15

Editor-in-chief of the Lancet Lancet Regional Health – Europe to share insight on how to get published and make an impact in society

On the 6th of March Pooja Jha, Editor-in-chief of the Lancet Regional Health –Europe, visits Alrek to meet researchers and students.

06.03.2023 – 09.00–10.30
Midgard Auditorium. Alrek Helseklyngen
Andrea Magugliani

Påmeldingsfrist: 01.03.2023 – 16.00

Registration

https://www.uib.no/pandemi/159697/editor-chief-lancet-lancet-regional-health-%E2%80%93-europe-share-insight-how-get-published

Bergen Summer Research School 2023

Kindly disseminate widely the Bergen Summer Research School 2023! https://www.uib.no/en/rs/bsrs

Please take a closer look and invite, re-post, tweet and share in your respective networks, and please like and share what is shared!

Your positions and networks are highly valued, and also, hopefully your network’s PhDs may benefit a lot from BSRS 2023.

The application deadline is 1st February 2023.

All courses are developing extremely nicely and I would warmly recommend them for our PhDs near and far!
https://www.facebook.com/BergenSummerResea
#BSRS2023

I recommend Counting every child for PhD candidates in child health and related

I recommend Food and nutrtion security in childhood for PhD candidates in child nutrition and related

I recommend Responsive caregiving in Complex emergencies for PhD candidates in child psychology, pedagogics and related

Those interested in sustainability, democratic processes, school and eduction, check this out

And lastly migration: Please check this out

It is an excellent opportunity to gather people in Bergen!

Ingunn
#BSRS2023

Kronprins Haakons forskningspris

Styret i Forskningsfondet for Astma og Allergi har siden 2016 delt ut Kronprins Haakons forskningspris for astma og allergi (naaf.no)

Prisen deles ut årlig til en forsker som har utvist en særskilt innsats innenfor fagfeltet astma og allergi.

Norges Astma- og Allergiforbund ønsker nominasjoner til forskningsprisen 2023

Frist for innsendelse av forslag er 5. mars.

Mer informasjon her

CCBIO Junior Scientist Symposium   

We are happy to invite you to the CCBIO Junior Scientist Symposium Thursday February 2, 2023, from 09:00-13:00, at B301, Sentralblokka, Haukeland University Hospital.

This seminar series is a perfect place to meet and interact with other young scientists. We anticipate lively and interesting discussion also this time. We are looking forward to the keynote lecture by CCBIO researcher Harsh Dongre, who will talk about how to make the jump of academic independence and establish your own research group. The program spans several exiting topics including small molecule drug discovery in prostate cancer, PDX models as preclinical tools for investigating myelodysplastic syndromes (MDS), mitochondrial trafficking in the tumor microenvironment and the role of CEL in pancreatic disease. Join us for a perfect occasion for professional input and networking!

Please register within January 30th at 11.00 if you want the FREE LUNCH which is included. If you don’t need the lunch, you can also register later.

When: Thursday February 2, 2023, 09:00-13:00

Where: Auditorium B301, Sentralblokka, Haukeland University Hospital, 3rd floor.

Who: Mostly intended for PhD students and other young researchers, but open for all, and senior scientists are very welcome.

Registration: Use this link (also even if you have registered for CCBIO901 in Studentweb.) There is no charge.

General information: More information about the Junior Scientist Symposia can be found here.

ECTS: Part of CCBIO901, with 3 credits (participation in the program through 2 terms.) All are however welcome for non-ECTS drop-in on each individual symposium.

Les videre

[Innovators in Science Award] 2-Weeks Until Nominations Open on February 1, 2023

On behalf of the New York Academy of Sciences, I am pleased to invite University of Bergen to submit two nominations for the 2024 Innovators in Science Award.

Established in November 2016, the Innovators in Science Award is a global award recognizing a promising Early-Career Scientist’s and an outstanding Senior Scientist’s contributions to biomedical science and is intended to support their commitment to innovative research. Two prizes of US$200,000 are awarded each Award cycle to winning scientists who have distinguished themselves for the creativity and impact of their research in a designated therapeutic area.  The award is administered by the New York Academy of Sciences and sponsored by Takeda Pharmaceuticals.

To draw attention to the increasing global cancer burden, the 2024 Innovators in Science Award will recognize scientists from around the globe for their exceptional research in Cancer Immunology. Cancer remains the second leading cause of death worldwide, exacerbated by the difficulty in progressing novel therapeutics from the research lab to the clinic.

Les videre